Medipress Health LP

Chart & Performance

D1W1MN

P/E

—

P/S

—

EPS

Div Yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

Revenues

Net income

CFO

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

MediPress Health-Limited Partnership is a venture capital firm and a life science research and development entity, primarily investing early-stage capital in startup companies. It targets businesses focused on innovation within the medical R&D sector. Its portfolio companies are actively involved in developing advanced treatments, including proton radiation therapy for cancer and non-surgical vaginal solutions for women experiencing various pelvic floor disorders. The partnership typically aims for strategic involvement by securing board positions within its investee companies. Established in 2021, MediPress Health-Limited Partnership is headquartered in Ramat Gan, Israel.

URL

http://medipressventures.com/

IPO date

Dec 30, 2021

Employees

Domiciled in

Incorporated in

Valuation

No data to show